Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


(Plasmid #159614)


Item Catalog # Description Quantity Price (USD)
Plasmid 159614 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Backbone manufacturer
    Addgene Plasmid #26107
  • Backbone size w/o insert (bp) 5515
  • Total vector size (bp) 7327
  • Vector type
    Bacterial Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Kanamycin, 50 μg/mL
  • Growth Temperature
  • Growth Strain(s)
  • Copy number
    Low Copy


  • Gene/Insert name
    Covid-SARS2 Nsp13
  • Species
    Synthetic; COVID-SARS2
  • Insert Size (bp)
  • Mutation
    Codon-optimized for E. coli expression
  • GenBank ID
  • Promoter T7 - LacO
  • Tag / Fusion Protein
    • His6-Zb-TEV (N terminal on backbone)

Cloning Information

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    COVID-SARS2 NSP13 was a gift from Opher Gileadi (Addgene plasmid # 159614 ; ; RRID:Addgene_159614)
  • For your References section:

    Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Newman JA, Douangamath A, Yadzani S, Yosaatmadja Y, Aimon A, Brandao-Neto J, Dunnett L, Gorrie-Stone T, Skyner R, Fearon D, Schapira M, von Delft F, Gileadi O. Nat Commun. 2021 Aug 11;12(1):4848. doi: 10.1038/s41467-021-25166-6. 10.1038/s41467-021-25166-6 PubMed 34381037